Full Paper
1
3
(q, JC,F = 270 Hz), 123.0 (q, JC,F = 10 Hz), 114.0, 57.7, 55.2, 25.4,
3 H), 3.27 (dd, J = 11.3, 9.9 Hz, 1 H), 2.94 (dd, J = 11.3, 2.6 Hz, 1 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 159.8, 145.5, 135.3, 131.6,
21.6 ppm. IR: ν = 2926, 2257, 1606, 1512, 1343, 1325, 1254, 1166,
˜
1133 cm–1. MS (EI): m/z = 526 [M]+. C23H20F3NO3SSe (526.43): calcd.
130.8, 127.9, 119.0, 115.8, 114.5, 108.5, 56.3, 55.5, 25.9 ppm. IR: ν =
˜
C 52.48, H 3.83, N 2.66; found C 52.51, H 3.79, N 2.60.
3365, 2939, 1583, 1512, 1465, 1251 cm–1. C15H14ClNOSe (338.69):
calcd. C 53.19, H 4.17, N 4.14; found C 53.12, H 4.20, N 4.10.
3-(4-Methoxyphenyl)-6-methyl-4-tosyl-3,4-dihydro-2H-benzo-
[b][1,4]selenazine (4e): The reaction mixture was heated in DMF
80 °C for 21 h. Purification by silica gel column chromatography
(dichloromethane/petroleum ether, 5:1, Rf = 0.50) gave derivative
3-(4-Methoxyphenyl)-6-(trifluoromethyl)-3,4-dihydro-2H-
benzo[b][1,4]selenazine (9): Thioacetic acid (4 μL, 0.06 mmol,
2.0 equiv.) and lithium hydroxide (3 mg, 0.12 mmol, 4.0 equiv.) were
added to a solution of 4g (17 mg, 0.03 mmol) in dry DMF (1.0 mL)
under nitrogen. The mixture was stirred at 60 °C for 24 h, then it
was diluted with EtOAc (20 mL), and washed with saturated aq.
NaHCO3 (15 mL). The organic phase was dried with anhydrous
Na2SO4, and the solvents were evaporated to dryness. Purification
by silica gel column chromatography (dichloromethane/petroleum
ether, 8:1, Rf = 0.67) gave derivative 9 (7 mg, 62 %) as a colourless
oil. 1H NMR [400 MHz,(CD3)2CO]: δ = 7.37–7.30 (m, 3 H), 7.06 (s, 1
H), 6.96–6.93 (m, 2 H), 6.82 (d, J = 8.0 Hz, 1 H), 5.76 (br. s, 1 H), 4.70
(dd, J = 9.2, 2.8 Hz, 1 H), 3.80 (s, 3 H), 3.30 (dd, J = 11.2, 9.2 Hz, 1
H), 3.07 (dd, J = 11.2, 2.8 Hz, 1 H) ppm. 13C NMR [100 MHz,(CD3)2CO]:
1
4e (57 mg, 75 %) as a pale yellow glassy solid. H NMR (400 MHz,
CDCl3): δ = 7.52 (d, J = 8.2 Hz, 1 H), 7.46–7.44 (m, 2 H), 7.32–7.29
(m, 2 H), 7.18–7.16 (m, 2 H), 7.03 (d, J = 1.3 Hz, 1 H), 6.97 (dd, J =
8.2, 1.3 Hz, 1 H), 6.81–6.77 (m, 2 H), 5.70 (at, J = 6.7 Hz, 1 H), 3.75
(s, 3 H), 3.32 (dd, J = 12.2, 6.7 Hz, 1 H), 3.01 (dd, J = 12.2, 6.7 Hz, 1
H), 2.40 (s, 3 H), 2.25 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
159.0, 143.6, 137.0, 132.9, 132.4, 131.1, 130.9, 129.4, 128.4, 127.9,
127.8, 127.6, 114.0, 59.7, 55.3, 29.8, 26.9, 21.7 ppm. IR: ν = 2962,
˜
2928, 2852, 1610, 1512, 1348, 1251, 1165 cm–1. C23H23NO3SSe
(472.46): calcd. C 58.47, H 4.91, N 2.96; found C 58.54, H 5.01, N
3.02.
2
δ = 161.5, 147.5, 137.3, 135.8, 131.8, 129.8, 129.4 (q, JC,F = 30 Hz),
6-Chloro-3-(4-methoxyphenyl)-4-[(2-nitrophenyl)sulfonyl]-3,4-
dihydro-2H-benzo[b][1,4]selenazine (4f): The reaction mixture
was heated in DMF 80 °C for 90 h. Purification by silica gel column
chromatography (dichloromethane/petroleum ether, 3:1, Rf = 0.70)
gave derivative 4f (60 mg, 72 %) as a brown glassy solid. 1H NMR
(400 MHz, CDCl3): δ = 7.70–7.66 (m, 1 H), 7.60 (d, J = 2.2 Hz, 1 H),
7.57–7.54 (m, 1 H), 7.49–7.45 (m, 1 H), 7.39–7.37 (m, 1 H), 7.30–7.25
(m, 3 H), 7.15 (dd, J = 8.3, 2.2 Hz, 1 H), 6.83–6.80 (m, 2 H), 5.94 (at,
J = 7.4 Hz, 1 H), 3.77 (s, 3 H), 3.53 (dd, J = 16.0, 7.4 Hz, 1 H), 3.11
(dd, J = 16.0, 7.4 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
159.4, 136.5, 134.1, 132.8, 132.0, 131.9, 131.8, 131.6, 131.2, 130.9,
1
3
126.5 (q, JC,F = 270 Hz), 115.9, 115.4 (q, JC,F = 10 Hz), 113.9 (q,
3JC,F = 10 Hz), 57.3, 56.6, 27.3 ppm. IR: ν = 2928, 1601, 1512, 1464,
˜
1325, 1250, 1173, 1127, 1079 cm–1. C16H14F3NOSe (372.25): calcd. C
51.63, H 3.79, N 3.76; found C 51.37, H 3.35, N 3.83.
3-(4-Methoxyphenyl)-4-tosyl-6-(trifluoromethyl)-3,4-dihydro-
2H-benzo[b][1,4]selenazine 1-Oxide (10): A solution of mCPBA
(9 mg, 0.054 mmol, 0.95 equiv.) in dry CH2Cl2 (1 mL) was added to
a solution of 4a (26 mg, 0.057 mmol) in dry CH2Cl2 (1 mL) at 0 °C.
The mixture was stirred at 0 °C for 20 min, then it was diluted with
CH2Cl2 (20 mL), washed with Na2SO3 (20 mL) and with saturated
aq. NaHCO3 (20 mL), and dried with anhydrous Na2SO4. The solvents
were evaporated to dryness to give derivative 10 (31 mg, 95 %)
without further purification, m.p. 55–57 °C. 1H NMR (CDCl3,
400 MHz): δ = 7.79–7.76 (m, 1 H), 7.56–7.52 (m, 3 H), 7.42–7.39 (m,
2 H), 7.26–7.23 (m, 2 H), 7.16–7.14 (m, 2 H), 6.82–6.79 (m, 2 H), 5.59
(dd, J = 9.8, 7.8 Hz, 1 H), 3.94 (dd, J = 11.8, 7.8 Hz, 1 H), 3.76 (s, 3
H), 2.99 (dd, J = 11.8, 9.8 Hz, 1 H), 2.42 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 159.4, 144.9, 135.2, 133.4, 131.8, 131.6, 131.2,
130.1, 129.0, 128.1, 127.1, 126.3, 114.3, 55.8, 55.3, 54.5, 21.6 ppm.
MS: m/z (%) = 459 (28), 304 (80), 223 (60), 134 (64), 91 (100).
C22H21NO4SSe (474.43): calcd. C 55.70, H 4.46, N 2.95; found C 55.83,
H 4.57, N 2.99.
129.0, 128.1, 123.9, 114.3, 61.2, 55.4, 28.6 ppm. IR: ν = 2931, 1544,
˜
1514, 1374, 1251, 1177 cm–1. C21H17ClN2O5SSe (523.85): calcd. C
48.15, H 3.27, N 5.35; found C 48.24, H 3.15, N 5.41.
3-(4-Methoxyphenyl)-4-[(2-nitrophenyl)sulfonyl]-6-(trifluoro-
methyl)-3,4-dihydro-2H-benzo[b][1,4]selenazine (4g): The reac-
tion mixture was heated in toluene at 110 °C for 240 h. Purification
by silica gel column chromatography (dichloromethane/petroleum
ether, 3:1, Rf = 0.70) gave derivative 4g (74 mg, 83 %) as a white
solid, m.p. 157–160 °C. 1H NMR (400 MHz, CDCl3): δ = 7.74–7.68 (m,
2 H), 7.60–7.58 (m, 1 H), 7.53–7.49 (m, 1 H), 7.46–7.42 (m, 2 H), 7.37–
7.35 (m, 1 H), 7.30–7.27 (m, 2 H), 6.80 (d, J = 8.0 Hz, 2 H), 5.97 (at,
J = 8.0 Hz, 1 H), 3.75 (s, 3 H), 3.63 (dd, J = 12.0, 8.0 Hz, 1 H), 3.23
(dd, J = 12.0, 8.0 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
159.2, 148.0, 135.5, 134.8, 134.2, 132.0, 131.3, 131.1, 130.9, 130.6,
6-Chloro-3-(4-methoxyphenyl)-3,4-dihydro-2H-benzo[b][1,4]-
selenazine 1-Oxide (11): A solution of mCPBA (4 mg, 0.022 mmol,
0.95 equiv.) in dry CH2Cl2 (0.5 mL) was added to a solution of 8
(8 mg, 0.024 mmol) in dry CH2Cl2 (0.5 mL) at 0 °C. The mixture was
stirred at 0 °C for 2 h. Purification by silica gel column chromatogra-
phy (EtOAc/MeOH, 10:1, Rf = 0.45) gave derivative 11 (4 mg, 50 %)
2
3
129.2 (q, JC,F = 30 Hz), 127.9, 127.8 (q, JC,F = 10 Hz), 123.9, (q,
2JC,F = 30 Hz), 123.5 (q, JC,F = 270 Hz), 114.1, 59.6, 55.2, 27.3 ppm.
1
IR: ν = 3650, 2932, 1545, 1513, 1326, 1176, 1136 cm–1
.
˜
C22H17F3N2O5SSe (557.40): calcd. C 47.40, H 3.07, N 5.03; found C
47.72, H 3.22, N 5.21.
1
as a white solid. H NMR (400 MHz, CDCl3): δ = 7.46 (d, J = 8.3 Hz,
6-Chloro-3-(4-methoxyphenyl)-3,4-dihydro-2H-benzo[b][1,4]-
selenazine (8): Thioacetic acid (17 μL, 0.24 mmol, 4.0 equiv.) and
lithium hydroxide (14 mg, 0.48 mmol, 8.0 equiv.) were added to a
solution of 4f (30 mg, 0.06 mmol) in dry DMF (3.0 mL) under nitro-
gen. The mixture was stirred at 60 °C for 72 h, then it was diluted
with EtOAc (20 mL), and washed with saturated aq. NaHCO3
(15 mL). The organic phase was dried with anhydrous Na2SO4, and
the solvents were evaporated to dryness. Purification by silica gel
column chromatography (dichloromethane/petroleum ether, 3:1,
Rf = 0.80) gave derivative 8 (11 mg, 55 %) as a colourless oil. 1H
NMR (400 MHz, CDCl3): δ = 7.29–7.26 (m, 2 H), 7.08 (d, J = 8.0 Hz,
1 H), 6.94–6.90 (m, 2 H), 6.62 (dd, J = 8.0, 2.0 Hz, 1 H), 6.49 (d, J =
2.0 Hz, 1 H), 4.63 (dd, J = 9.9, 2.6 Hz, 1 H), 4.08 (br. s, 1 H), 3.82 (s,
1 H), 7.43–7.40 (m, 2 H), 6.97–6.93 (m, 2 H), 6.76 (dd, J = 8.3, 1.9 Hz,
1 H), 6.72 (d, J = 1.9 Hz, 1 H), 5.12–5.08 (m, 1 H), 4.63 (s, 1 H), 3.84
(s, 3 H), 3.04–2.93 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
160.3, 146.3, 139.5, 134.2, 132.1, 128.6, 127.9, 118.6, 116.9, 114.9,
55.6, 47.2, 29.9 ppm. IR: ν = 3689, 2928, 2852, 2359, 2253, 1591,
˜
1512, 1466, 1251, 1092 cm–1. C15H14ClNO2Se (354.69): calcd. C 50.79,
H 3.98, N 3.95; found C 50.91, H 3.87, N 3.91.
GPx-Like Catalytic Activity:[12b] In the NMR assay, DTTred
(0.15 mmol) and Se catalyst (0.015 mmol) were dissolved in CD3OD
(1.1 mL), and the solution was added to H2O2 (35 % aq.; 15 μL,
0.15 mmol) to start the reaction. 1H NMR spectra were measured at
variable reaction times at 25 °C. The relative populations of DTTred
Eur. J. Org. Chem. 0000, 0–0
5
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim